Diagnosis and treatment of thrombotic microangiopathy

Gemma L Thompson1,2, David Kavanagh1,2

  • 1Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Insights

Thrombotic microangiopathy (TMA) involves low platelets, red blood cell destruction, and organ damage. Recent research has led to targeted treatments, improving outcomes for this serious condition.

Area of Science:

  • Hematology
  • Nephrology
  • Pathophysiology

Background:

  • Thrombotic microangiopathy (TMA) presents with thrombocytopenia, microangiopathic hemolytic anemia, and end-organ damage.
  • Kidney involvement is frequent due to susceptibility to endothelial damage and microvascular occlusion.
  • TMAs necessitate prompt evaluation, diagnosis, and treatment due to high morbidity and mortality.

Purpose of the Study:

  • To review the clinical presentations of TMAs.
  • To discuss the underlying pathogenesis of TMAs.
  • To outline diagnostic tests and treatments for TMAs.

Main Methods:

  • Literature review of thrombotic microangiopathy.
  • Synthesis of recent advancements in TMA pathogenesis.
  • Compilation of diagnostic and therapeutic strategies for TMAs.

Main Results:

  • TMAs exhibit diverse clinical presentations based on underlying pathophysiology.
  • Advances in understanding TMA pathogenesis have enabled targeted therapies.
  • Effective management relies on timely diagnosis and appropriate treatment initiation.

Conclusions:

  • This review provides a comprehensive overview of TMAs.
  • Understanding TMA pathophysiology is key to developing effective treatments.
  • Targeted therapeutics have significantly improved patient outcomes in TMAs.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
37
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
29
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
26
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
861